KG
Kelsey Goodwin Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
54%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.3%
Neutral
8.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $18 |
38%
upside
| 3 | +70% |
0
%
| 13 Mar ‘26 2 months ago |
|
|
|
Neutral
Downgraded
| $115 |
0%
downside
| 1 | – |
–
| 26 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $120 |
22%
downside
| 2 | +90% |
0
%
| 26 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $14 |
35%
downside
| 2 | +57% |
0
%
| 16 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $30 |
119%
upside
| 2 | -22% |
0
%
| 16 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $70 |
24%
upside
| 2 | +62% |
0
%
| 16 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $8 |
277%
upside
| 2 | -26% |
0
%
| 16 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $24 |
452%
upside
| 1 | +6.8% |
0
%
| 7 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $22 |
196%
upside
| 1 | +51% |
0
%
| 7 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $26 |
21%
upside
| 1 | +192% |
0
%
| 5 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $128 |
38%
upside
| 2 | +16% |
0
%
| 27 Oct ‘25 7 months ago |
|
|
|
Neutral
Initiated
| $21 |
41%
upside
| 1 | – |
–
| 19 Aug ‘25 9 months ago |
|
|
|
Overweight
Initiated
| $36 |
36%
upside
| 3 | +24% |
0
%
| 19 Aug ‘25 9 months ago |
|
|
|
Overweight
Initiated
| $36 |
81%
upside
| 1 | +70% |
0
%
| 19 Aug ‘25 9 months ago |
|